Search
for
Sort by
Research 391–420 of 1000+
- Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis
- Is dehydroepiandrosterone a hormone?
- Clinical applications of antiandrogens
- Ovarian hyperthecosis in adolescent females: two case reports and a review of the literature
- Gender Differences in Production and Circulating Levels of Sex Hormones and Their Impact on Aging Skin
- Hirsutism and virilization
- Virilization in a postmenopausal woman: Ovarian Leydig cell tumor
- Pharmakokinetik und Biokonversion von Dehydroepiandrosteron nach Dexamethason-Vorbehandlung bei Frauen mit dem Syndrom der polyzystischen Ovarien
- Dihydrotestosterone and 5α-Reductase
- Rare Conditions of Hyperandrogenism Through Lifespan: A Case Series
- Is Dutasteride a Therapeutic Alternative for Amyotrophic Lateral Sclerosis?
- LBODP010 A Case of Glucocorticoid Resistance Syndrome
- SAT-223 Insights into Ovarian Hyperandrogenism: Lessons from Two Unusual Cases
- Diphenyl cresyl phosphate [MAK Value Documentations, 2003]
- Polycystic ovary syndrome
- Androgens/Androgen Receptor in the Management of Skin Diseases
- Management of “hyperandrogenism” confounded by dermatology biotin prescriptions
- Genetics and Epigenetics of Polycystic Ovary Syndrome
- Serum prolactin and dehydroepiandrosterone concentrations during the summer and winter hair growth cycles of mink (Mustela vison)
- Melatonin induces a stimulatory action on the scrotal skin components of Soay ram in the non-breeding season
- Polycystic Ovary Syndrome: Explaining the Gynecological Aspects and Treatment Options to Patients
- The brain–gut–skin axis in inflammatory and disfiguring skin diseases: mechanistic insights, clinical correlations, and therapeutic strategies
- Novel Synthetic Steroid Derivatives: Target Prediction and Biological Evaluation of Antiandrogenic Activity
- Postmenopausal hyperandrogenism of ovarian origin
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Evidence-based approach to cutaneous hyperandrogenism in women
- Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?
- Hormonal therapy for acne: why not as first line therapy? facts and controversies
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Treatment guidelines in adult women